Pricing Log in Create free account

Genelux Corporation (GNLX) vs Novogen Limited (KZIA)

Genelux Corporation and Novogen Limited are both Biotechnology companies. Genelux Corporation and Novogen Limited are of similar size ($92.4M and $88.7M). Across the 9 metrics below, Novogen Limited leads on 8 and Genelux Corporation on 1.

Valuation

Metric GNLX KZIA Biotechnology median
P/E n/m n/m 10.26
P/S 7.24 — 9.18
P/B 5.05 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 1.46 0.65
EV/Sales 6.33 n/m 8.98
Earnings yield (47.51%) (3.03%) (34.89%)
Free cash flow yield (35.25%) 0.00% (24.52%)

Profitability

Metric GNLX KZIA Biotechnology median
Gross margin (3.42%) 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (177.93%) 0.00% (50.12%)
Return on assets (121.80%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNLX KZIA Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 9.47% 63.24% 29.88%
Revenue growth, 5-year CAGR — 11.56% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNLX KZIA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.39 2.87 4.89
Net debt to EBITDA 0.44 0.30 1.01

Dividend

Metric GNLX KZIA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GNLX KZIA Biotechnology median
Market cap 88.68m 92.35m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack